ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 161 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $283,772,861 | -14.5% | 13,616,740 | -1.7% | 0.01% | -12.5% |
| Q2 2023 | $331,823,561 | +28.9% | 13,854,846 | +1.3% | 0.01% | +14.3% |
| Q1 2023 | $257,435,185 | +21.8% | 13,678,809 | +3.0% | 0.01% | +16.7% |
| Q4 2022 | $211,414,018 | -0.0% | 13,279,775 | +2.7% | 0.01% | 0.0% |
| Q3 2022 | $211,463,000 | +21.0% | 12,925,641 | +4.2% | 0.01% | +20.0% |
| Q2 2022 | $174,724,000 | -42.7% | 12,400,593 | -1.4% | 0.01% | -28.6% |
| Q1 2022 | $304,707,000 | +6.0% | 12,580,814 | +2.2% | 0.01% | 0.0% |
| Q4 2021 | $287,441,000 | +42.7% | 12,315,366 | +1.5% | 0.01% | +40.0% |
| Q3 2021 | $201,468,000 | -28.3% | 12,129,266 | +5.3% | 0.01% | -28.6% |
| Q2 2021 | $280,932,000 | +0.3% | 11,518,317 | +6.1% | 0.01% | -12.5% |
| Q1 2021 | $280,218,000 | -50.6% | 10,861,175 | +2.4% | 0.01% | -50.0% |
| Q4 2020 | $566,984,000 | +32.6% | 10,605,773 | +2.3% | 0.02% | +14.3% |
| Q3 2020 | $427,750,000 | -17.2% | 10,369,690 | -2.7% | 0.01% | -22.2% |
| Q2 2020 | $516,759,000 | +11.4% | 10,661,419 | -2.9% | 0.02% | -10.0% |
| Q1 2020 | $464,033,000 | +2.2% | 10,983,037 | +3.5% | 0.02% | +33.3% |
| Q4 2019 | $454,179,000 | +20.1% | 10,616,613 | +1.0% | 0.02% | +7.1% |
| Q3 2019 | $378,278,000 | +48.9% | 10,510,624 | +10.6% | 0.01% | +40.0% |
| Q2 2019 | $254,071,000 | -0.4% | 9,505,082 | +0.1% | 0.01% | 0.0% |
| Q1 2019 | $255,012,000 | +55.5% | 9,497,642 | -6.4% | 0.01% | +42.9% |
| Q4 2018 | $163,990,000 | -10.5% | 10,141,664 | +14.9% | 0.01% | 0.0% |
| Q3 2018 | $183,303,000 | +38.4% | 8,829,618 | +1.8% | 0.01% | +16.7% |
| Q2 2018 | $132,459,000 | -27.7% | 8,674,446 | +6.4% | 0.01% | -25.0% |
| Q1 2018 | $183,270,000 | -23.8% | 8,156,164 | +2.1% | 0.01% | -27.3% |
| Q4 2017 | $240,434,000 | -17.9% | 7,985,197 | +2.7% | 0.01% | -21.4% |
| Q3 2017 | $292,752,000 | +38.0% | 7,771,508 | +2.2% | 0.01% | +40.0% |
| Q2 2017 | $212,093,000 | -17.4% | 7,604,605 | +1.8% | 0.01% | -23.1% |
| Q1 2017 | $256,812,000 | +25.0% | 7,469,785 | +4.9% | 0.01% | +18.2% |
| Q4 2016 | $205,388,000 | -6.0% | 7,121,644 | +3.7% | 0.01% | -15.4% |
| Q3 2016 | $218,502,000 | +5.7% | 6,868,996 | +7.9% | 0.01% | 0.0% |
| Q2 2016 | $206,737,000 | +17.0% | 6,368,960 | +0.8% | 0.01% | +18.2% |
| Q1 2016 | $176,694,000 | -11.5% | 6,319,539 | +12.8% | 0.01% | -15.4% |
| Q4 2015 | $199,699,000 | -72.9% | 5,601,656 | -72.4% | 0.01% | -53.6% |
| Q3 2015 | $737,616,000 | +232.1% | 20,268,112 | +282.2% | 0.03% | +86.7% |
| Q2 2015 | $222,089,000 | +32.8% | 5,302,962 | +3.3% | 0.02% | +36.4% |
| Q1 2015 | $167,231,000 | +7.9% | 5,131,359 | +5.1% | 0.01% | 0.0% |
| Q4 2014 | $155,011,000 | +29.6% | 4,882,201 | +1.1% | 0.01% | +22.2% |
| Q3 2014 | $119,606,000 | +9.6% | 4,830,617 | +0.0% | 0.01% | 0.0% |
| Q2 2014 | $109,102,000 | -6.4% | 4,829,652 | +0.8% | 0.01% | -10.0% |
| Q1 2014 | $116,538,000 | +8.1% | 4,789,894 | +11.0% | 0.01% | +11.1% |
| Q4 2013 | $107,847,000 | +1.3% | 4,315,613 | +11.3% | 0.01% | -10.0% |
| Q3 2013 | $106,501,000 | +100.8% | 3,877,013 | +32.7% | 0.01% | +66.7% |
| Q2 2013 | $53,042,000 | – | 2,922,469 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |